EARNINGS REPORT by CSIMarket
Outstanding EPS Increase on Weak Sales
Genuine Parts Co announced fourth quarter 2020 operating surplus of $214.78 millions
For the fourth quarter 2020 earnings per share soared by 1826.47 % to $1.18 per share, despite Sales decrease of -19.58 % to $ 3.78 billions, year on year. ![]() From preceding quarter, income faded by -25.07 % from $1.57 per share and Sales deteriorated by -13.4 % from $4.37 billions. Sales fell at Automotive -0.34%, Industrial -1.75%, Other 28.51%, while revenue growth was achieved at Office Products +14.08%, Electrical or electronic materials +3.55%. Net earnings increase of 1819.76 % in the fourth quarter 2020 was supported by expanding profits in Automotive and Office Products businesses, 0.37% and 10.64% respectively, while profits recoiled in Industrial segment. Producing overall net income of $171.204 millions for the fourth quarter 2020, compare to income of $8.918 millions achieved a year before. Genuine Parts Co also emphasized it's improving profit margins, where net margin rose to 4.52% in fourth quarter 2020, and operating margin edged up to 5.68%. Genuine Parts Co reported net loss of $ -29 millions and Sales of $ 16.54 billions for the fiscal year 2020. Automotive Aftermarket company said its eps were at $-0.20 compare to $4.24 in the previous fiscal year, while Sales deteriorated by -14.72 % from $19.39 billions a year ago. Genuine Parts Co is expected to report next financial results on April 20, 2021.
|
Recently Reported Results |
Ikonics Corp
For the fourth quarter 2020 earnings per share soared by 1826.47 % to $1.18 per share, despite Sales decrease of -19.58 % to $3.78 billions, year on year.
From the preceding quarter, EPS turn positive from $-0.14 per share and Sales surged by 34.85 % from $3.13 millions. Ikonics Corp reported net loss of $-0.44 millions and Sales of $13.43 millions for the fiscal year 2020. Company has decreased loss per share to $-0.22 from $-0.41 in the previous fiscal year, while Sales fell by -23.76 % from $17.62 millions a year ago.
IKNX stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Producer Price Index
|
Red Robin Gourmet Burgers inc
Company's earnings faded on asset impairments of $149.47 million in the most recent fiscal period
Sales faded by -33.63% to $201.05 millions from $302.95 millions in the same quarter a year ago and sequentially Sales increased by 0.29 % from $200.48 millions. Red Robin Gourmet Burgers Inc reported net loss of $-276.07 millions and Sales of $868.72 millions for the fiscal year 2020. Net loss per share has widen to $-19.29 from $-0.61 in previous fiscal year, while Sales Tumbled by -33.94 % from $1.32 billions a year ago.
RRGB stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Martin Midstream Partners L p
Martin Midstream Partners L P recorded operating income of $23.531 millions, in the most recent fiscal period, a progress from the operating profit of $16.925 millions, reported in fourth quarter of 2019
Sales grew strongly by 53.76% to $355.06 millions from $230.93 millions in the same quarter a year ago and sequentially Sales doubled by 132.78 % from $152.53 millions. Martin Midstream Partners L P reported net loss of $-6.48 millions and Sales of $672.14 millions for the fiscal year 2021. Company reported break-even compared to $0.00 in the previous fiscal year, while Sales fell by -20.66 % from $847.12 millions a year ago.
MMLP stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Bluelinx Holdings Inc
Due to strong revenue growth company turned into profitability, Sales grew by 25.07% to $848.82 millions, earnings per share were at $2.77, compared to $-0.75 in the same quarter a year ago.
Sequentially profit plummeted by -51.6% from $5.72 per share and Sales decreased by -2.55% from $871.06 millions. Bluelinx Holdings Inc reported earnings of $80.88 millions and Sales of $3.10 billions for the fiscal year 2020. Company reported earnings per share of $8.55 compared to $-1.89 in the previous fiscal year, while Sales improved by 17.44 % from $2.64 billions a year ago.
BXC stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Housing Starts
|
Durable Goods Orders
New orders increased on the faster pace again, excluding defense booking grew even faster 1.05 %. That category excludes defense and gives a better indication of longer-term trends in the private sector.
|
Factory Orders
Factory orders continued to grow, excluding defense, booking grew even faster 1.56 %. That category excludes defense and gives a better indication of longer-term trends in the private sector.
|
Calumet Specialty Products Partners L p
Weak demand caused increase in losses for the fiscal fourth quarter of 2020, company's deficit per share grew to $-0.51 from $-0.48 where Sales fell by -28.51% to $553.90 millions from $774.80 millions a year ago.
In contrast to the third quarter Sales decreased by -2.48% from $568.00 millions and improved from $-0.70 per share. Calumet Specialty Products Partners L P reported net loss of $-149.00 millions and Sales of $2.27 billions for the fiscal year 2020. Net loss per share has widen to $-1.86 from $-0.55 in previous fiscal year, while Sales Tumbled by -34.3 % from $3.45 billions a year ago.
CLMT stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Kallo Inc
In the financial fourth quarter of 2020 Kallo Inc increased losses of $-0.03 per share compared to $-0.00 a year ago and increased losses from $-0.01 per share from the previous quarter.
Kallo Inc reported operating loss of $-35.557435 millions, in the financial fourth quarter of 2020, a deterioration from the operating shortfall of $-1.728984 millions, realized in fourth quarter of 2019 Kallo Inc reported net loss of $-36.06 millions and Sales of $0.00 millions for the fiscal year 2020. Net loss per share has widen to $-0.03 from $-0.01 in previous fiscal year, while by 0 % from $0.00 millions a year ago.
KALO stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Ampio Pharmaceuticals inc
In the fourth quarter of 2020 earnings season Ampio Pharmaceuticals Inc loss increased of $-0.02 per share compared to $-0.01 a year ago and from $-0.02 per share from the previous quarter.
Ampio Pharmaceuticals Inc reported operating shortfall of $-3.911 millions, in the fourth quarter of 2020 earnings season, an improvement from the operating shortfall of $-7.145966 millions, realized in fourth quarter of 2019 Ampio Pharmaceuticals Inc reported net loss of $-15.89 millions and Sales of $0.00 millions for the fiscal year 2020. Company has decreased loss per share to $-0.09 from $-0.14 in the previous fiscal year, while by 0 % from $0.00 millions a year ago.
AMPE stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Cowen inc
Cowen Inc delivered very strong results in the fiscal period ending Dec 31 2020, where Sales soared by 78.89% to $502.92 millions, while company's earnings per share soared by 2512.48 % to $3.00 per share, from the same quarter a year ago.
In contrast to the third quarter Sales improved by 29.71 % from $387.74 millions and eps more than doubled by 383.3 % from $0.62 per share. In the fiscal year 2020, Cowen Inc reported Sales of $1.62 billions and net income of $207.06 millions. Eps surged by 1145.61 % to $7.10 per share from $0.57 in the previous fiscal year, while Sales surged by 54.68 % from $1.05 billions a year ago.
COWN stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Brown forman Corporation
Brown Forman Corporation reported declining eps on increasing revenue in the financial third quarter of 2020, where Sales grew by 3.74% to $1.22 billions in comparison to $1.18 billions on a year-over-year basis, while earnings decreased by -6.25% to $0.45 per share, income per share was $0.48 in the same quarter a year ago.
In the previous quarter company realized Sales of $1.27 billions and bottom line of $0.50 per share.
BFA stock quotes, charts, profile
Growth Rates, Profitability, PE
|
Annovis Bio Inc
For the fourth quarter of 2020 earnings season Annovis Bio Inc lost money at $-0.25 per share, compared to results of $-0.87 per share a year ago quarter, In the previous quarter company realized $-0.15 per share.
from $0.00 millions in preceding quarter, increased losses from $-0.15 per share. Annovis Bio Inc reported net loss of $-5.46 millions and Sales of $-0.03 millions for the fiscal year 2020. Company recorded loss per share of $-0.87 compared to $1.73 in the previous fiscal year, while by -100 % from $4.28 billions a year ago.
ANVS stock quotes, charts, profile
Growth Rates, Profitability, PE
|
|
|
|
|
|
|